VR手术机器人研发公司Vicarious Surgical（RBOT）宣布管理层更迭及战略调整，将重点转向生产系统准备阶段，预计现金消耗控制在5000万美元。该公司现阶段优先考虑系统设计而非短期临床应用。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.